$HEXO

HEXO Corp

  • NASDAQ
  • Pharmaceuticals: Other
  • Health Technology
  • Process Industries
  • Agricultural Commodities/Milling
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$0.2501 β–Ό-3.734%

Extented Hours

VOLUME

16,179,118

DAY RANGE

0.2298 - 0.26

52 WEEK

0.177 - 3.55

Join Discuss about HEXO with like-minded investors

profile
@dros #droscrew
recently

RECAP 5/3 Chatter: $HEXO - Offering $HR + $WELL $SAP + Litmos unit sale $AAPL Car + Hires $F Exec $ROKU + Ads & $MSFT collab $T + Raise mobile plan prices

68 Replies 13 πŸ‘ 14 πŸ”₯

profile
@viking #StockTraders.NET
recently

Upside: -ENOB +159% (announces FDA Acceptance of Pre-IND Request for Potential HIV Cure) -ITOS +51% (GSK and iTeos announce development and commercialisation collaboration for EOS-448) -CRSR +15% (hearing interest from WallStreetBets) -NVAX +9.0% (COVID-19 vaccine demonstrates 90% overall efficacy and 100% protection against moderate and severe disease in PREVENT-19 Phase 3 trial) -LPCN +8.3% (FDA clears LPCN 1154 IND application for a Phase 2 Postpartum Depression Study) -RIOT +8.3% (crypto strength following TSLA CEO Musk indicating car maker may resume BTC transactions) -HAPP +7.8% (signed agreement to distribute Volkswagen Electric Vehicles) -MARA +7.8% (crypto strength following TSLA CEO Musk indicating car maker may resume BTC transactions) -RAPT +7.7% (reports positive topline results from Phase 1b Trial of RPT193 Monotherapy in Atopic Dermatitis) -AMTX +6.0% (signs $200M biofuels offtake agreement with international renewable fuels supplier Murex, LLC to be delivered during 2021 to 2023) -OCC +5.4% (earnings) -EFOI +4.8% (enters marketing partnership with FirstEnergy Home and FirstEnergy Advisors) -TWST +3.2% (collaborates with Regeneron for production of genotyping by sequencing panel to enable diverse genome-wide screening) -HGEN +2.8% (initiates Submission for Lenzilumab Marketing Authorization in COVID-19, to the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA)) -CODA +2.3% (earnings) -OTLK +2.3% (announces inclusion in the Russell 2000 Index, effective June 25, 2021) -SVOK +1.1% (confirms Boxed to go public through merger with Seven Oaks Acquisition Corp. in deal valued at ~$900M) Downside: -ATXI -47% (receives Complete Response Letter from the FDA for IV Tramadol, saying it does not support benefits as a monotherapy) -RIDE -11% (CEO and CFO resign following results of special committee investigation of Hindenburg Research report) -HEXO -3.6% (earnings) -NKLA -1.5% (discloses entered into a purchase agreement and a registration rights agreement with Tumim Stone Capital to sell $300M of the Nikola's common stock)

60 Replies 9 πŸ‘ 14 πŸ”₯

profile
@ivtrades-Chris #ivtrades
recently

SWEEP DETECTED: >>1816 $HEXO May21 13.0 Calls trade $1.50 (FT Theo=1.49) ASKSIDE [MULTI] 13:05:13 IV=121.2% +7.2 OPENING 52WeekHigh Vol=1960, OI=736

71 Replies 13 πŸ‘ 14 πŸ”₯

profile
@dros #droscrew
recently

HEXO Corp. Granted Worldwide Patent Titled 'INDUSTRIAL-SCALE PROCESSING OF CANNABIS MATERIAL'

99 Replies 10 πŸ‘ 8 πŸ”₯

MB
@MB-2020 #ivtrades
recently

$HEXO bought @1 and sold @4

62 Replies 11 πŸ‘ 6 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

$HEXO penny

75 Replies 7 πŸ‘ 15 πŸ”₯

Key Metrics

Market Cap

115.47 M

Beta

1.41

Avg. Volume

9.40 M

Shares Outstanding

506.90 M

Yield

0%

Public Float

0

Next Earnings Date

2022-10-27

Next Dividend Date

Company Information

HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. The Company serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis.

CEO: Sebastien St-Louis

Website:

HQ: 3000 Solandt Road Ottawa, K2K 2X2 Ontario

Related News